Breaking News - The Fly

Open Search

IPSC

Century Therapeutics

$

()

Century Therapeutics price target lowered by $1 at Piper Sandler, here's why

IPSC

4/12/2024 - 08:13am

Century Therapeutics announces strategic pipeline expansion

IPSC

4/11/2024 - 07:09am

Century Therapeutics: Data from iPSC-derived cell therapy presented at AACR

IPSC

4/8/2024 - 16:15pm

Century Therapeutics price target raised by $2 at Canaccord, here's why

IPSC

3/15/2024 - 07:16am

Century Therapeutics expects cash to support operations into 2026

IPSC

3/14/2024 - 07:37am

Century Therapeutics reports 2023 EPS ($2.30), consensus ($2.09)

IPSC

3/14/2024 - 07:36am

Century Therapeutics presents initial data from CNTY-101 Phase 1 ELiPSE-1 trial

IPSC

12/10/2023 - 06:31am

Century Therapeutics receives FDA clearance of IND-application for CNTY-101

IPSC

12/6/2023 - 07:33am

Century Therapeutics, Fujifilm Cellular Dynamics enter license agreement

IPSC

11/9/2023 - 07:29am

Century Therapeutics appoints Pfeiffenberger as CEO

IPSC

11/9/2023 - 07:23am

Century Therapeutics reports Q3 EPS (55c), consensus (51c)

IPSC

11/9/2023 - 07:23am

Century Therapeutics to present data from Phase 1 ELiPSE-1 trial of CNTY-101

IPSC

11/2/2023 - 09:22am

Century Therapeutics downgraded to Neutral from Overweight at JPMorgan

IPSC

8/28/2023 - 04:34am

Century Therapeutics price target lowered to $10 from $14 at Piper Sandler

IPSC

8/10/2023 - 09:20am

Century Therapeutics price target lowered to $13 from $17 at H.C. Wainwright

IPSC

8/10/2023 - 06:23am